2022 - Research.com Best Female Scientist Award
Angela Dispenzieri spends much of her time researching Internal medicine, Multiple myeloma, Gastroenterology, Surgery and Pathology. Her research links Immunology with Internal medicine. Her Multiple myeloma study combines topics in areas such as Monoclonal gammopathy of undetermined significance and Dexamethasone.
Angela Dispenzieri has included themes like Antibody, Myeloma protein, Hazard ratio, Survival analysis and Risk factor in her Gastroenterology study. Her work is dedicated to discovering how Surgery, Clinical trial are connected with MEDLINE and other disciplines. Her Transplantation study combines topics from a wide range of disciplines, such as Stem cell and Oncology.
Angela Dispenzieri focuses on Internal medicine, Multiple myeloma, Surgery, Amyloidosis and Gastroenterology. Angela Dispenzieri works mostly in the field of Internal medicine, limiting it down to topics relating to Oncology and, in certain cases, Clinical trial. Her work carried out in the field of Multiple myeloma brings together such families of science as Monoclonal gammopathy of undetermined significance and Bone marrow, Pathology.
As part of her studies on Surgery, Angela Dispenzieri frequently links adjacent subjects like Cohort. She focuses mostly in the field of Amyloidosis, narrowing it down to matters related to Immunoglobulin light chain and, in some cases, Molecular biology. Her Gastroenterology research includes themes of Hazard ratio, Survival rate, Primary systemic amyloidosis, Myeloma protein and Survival analysis.
The scientist’s investigation covers issues in Internal medicine, Multiple myeloma, Amyloidosis, Oncology and AL amyloidosis. Many of her studies on Internal medicine apply to Gastroenterology as well. Her Gastroenterology study integrates concerns from other disciplines, such as Stage, Monoclonal gammopathy of undetermined significance, Progression-free survival and Survival rate.
Her research in Multiple myeloma intersects with topics in Newly diagnosed, Survival analysis and Bone marrow. Her Amyloidosis study which covers Immunoglobulin light chain that intersects with Monoclonal. The AL amyloidosis study combines topics in areas such as Hazard ratio, Retrospective cohort study, Melphalan and Very Good Partial Response.
Her scientific interests lie mostly in Internal medicine, Amyloidosis, Multiple myeloma, AL amyloidosis and Gastroenterology. In her study, which falls under the umbrella issue of Internal medicine, MEDLINE is strongly linked to Oncology. Her work deals with themes such as Immunoglobulin light chain, Amyloid, Hematologic Response and Cardiology, which intersect with Amyloidosis.
Her Multiple myeloma research incorporates themes from Newly diagnosed, Anemia, Hazard ratio, Confidence interval and Survival analysis. Her study looks at the intersection of Hazard ratio and topics like Surgery with Thalidomide. Her study on Gastroenterology also encompasses disciplines like
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.
S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade.
Lancet Oncology (2014)
Review of 1027 Patients With Newly Diagnosed Multiple Myeloma
Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust.
Mayo Clinic Proceedings (2003)
Improved survival in multiple myeloma and the impact of novel therapies
Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy.
Prevalence of Monoclonal Gammopathy of Undetermined Significance
Robert A. Kyle;Terry M. Therneau;S. Vincent Rajkumar;Dirk R. Larson.
The New England Journal of Medicine (2006)
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Jonathan J. Keats;Rafael Fonseca;Marta Chesi;Roelandt Schop.
Cancer Cell (2007)
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz.
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: A prospective study
Ola Landgren;Robert A. Kyle;Ruth M. Pfeiffer;Jerry A. Katzmann.
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
A. Dispenzieri;R. Kyle;G. Merlini;J. S. Miguel.
POEMS syndrome: definitions and long-term outcome.
Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;S. Vincent Rajkumar.
Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.
Robert A. Kyle;Ellen D. Remstein;Terry M. Therneau;Angela Dispenzieri.
The New England Journal of Medicine (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: